These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6508252)

  • 21. [Data on biology of nonagglutinating vibrions and their sensitivity to antibiotics].
    Dunaev GS; Zykin LF
    Antibiotiki; 1973 Sep; 18(9):839-44. PubMed ID: 4761957
    [No Abstract]   [Full Text] [Related]  

  • 22. [Sensitivity to antibiotics of El Tor cholera vibrions].
    Shvetsov RI; Ganin VS; Maramovich AS; Veĭde AA
    Antibiotiki; 1976 Sep; 21(9):816-7. PubMed ID: 999265
    [No Abstract]   [Full Text] [Related]  

  • 23. Class 1 integrons and SXT elements conferring multidrug resistance in Vibrio cholerae O1 strains associated with a recent large cholera outbreak in Orissa, Eastern India.
    Jain M; Kumar P; Goel AK; Kamboj DV; Singh L
    Int J Antimicrob Agents; 2008 Nov; 32(5):459-60. PubMed ID: 18706789
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effect of different isoniazid concentrations on the Mycobacterium tuberculosis variant highly resistant to the preparation].
    Bondarev IM; Dolgaia TM
    Probl Tuberk; 1980 Aug; (8):65-9. PubMed ID: 6773048
    [No Abstract]   [Full Text] [Related]  

  • 25. [Analysis of the data in the literature on the sensitivity of cholera vibrios to tetracycline].
    Semiotrochev VL; Filatov LG
    Antibiotiki; 1975 Jun; 20(7):623-8. PubMed ID: 5050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of the Vibrio cholerae vexAB and vexCD efflux systems.
    Bina JE; Provenzano D; Wang C; Bina XR; Mekalanos JJ
    Arch Microbiol; 2006 Sep; 186(3):171-81. PubMed ID: 16804679
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiple antibiotic resistance profiles of Vibrio cholerae non-O1 and non-O139.
    Kumar PA; Patterson J; Karpagam P
    Jpn J Infect Dis; 2009 May; 62(3):230-2. PubMed ID: 19468189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Inc J plasmids identified for the first time in Vibrio cholerae El Tor].
    Korichi MN; Belhocine S; Rahal K
    Med Trop (Mars); 1997; 57(3):249-52. PubMed ID: 9513150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changing patterns of Vibrio cholerae isolation over three consecutive cholera seasons (1992-1994) in east Delhi.
    Rudra S; Mathur M; Talwar V; Kathuria K
    J Commun Dis; 1997 Mar; 29(1):15-22. PubMed ID: 9282524
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vibrio cholerae O139 Bengal: emergence of a new epidemic strain of cholera.
    Morris JG
    Infect Agents Dis; 1995 Mar; 4(1):41-6. PubMed ID: 7728355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibacterial, antisecretory and antihemorrhagic activity of Azadirachta indica used to treat cholera and diarrhea in India.
    Thakurta P; Bhowmik P; Mukherjee S; Hajra TK; Patra A; Bag PK
    J Ethnopharmacol; 2007 May; 111(3):607-12. PubMed ID: 17314018
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Accelerated radioisotope method of determining cholera vibrios' sensitivity to antibiotics].
    Korol' VV; Podosinnikova LS; Golubinskiĭ EP; Rublev BD
    Antibiotiki; 1980 May; 25(5):353-6. PubMed ID: 7387130
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular mechanisms of virstatin resistance by non-O1/non-O139 strains of Vibrio cholerae.
    Shakhnovich EA; Sturtevant D; Mekalanos JJ
    Mol Microbiol; 2007 Dec; 66(6):1331-41. PubMed ID: 17986190
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antibiotic sensitivity of El Tor Vibrio cholerae after exposure to various pesticides and mineral fertilizers].
    Ziiaev ShI; Vallamatov ST; Zaĭtseva TS; Ismailov II
    Antibiot Khimioter; 1991 Aug; 36(8):37-9. PubMed ID: 1661574
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Mexican phenotype and genotype Vibrio cholerae 01].
    Giono S; Gutiérrez Cogno L; Rodríguez Angeles G; del Rio Zolezzi A; Valdespino González JL; Sepúlveda Amor J
    Gac Med Mex; 1995; 131(1):28-35; discussion 36-7. PubMed ID: 7493738
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disarming pathogens--a new approach for antibiotic development.
    Waldor MK
    N Engl J Med; 2006 Jan; 354(3):296-7. PubMed ID: 16421373
    [No Abstract]   [Full Text] [Related]  

  • 37. [The chemosensitivity of strains of Vibrio cholerae group O1 isolated in Romania between 1977-1995].
    Israil A; Năcescu N; Cedru C; Balotescu C
    Bacteriol Virusol Parazitol Epidemiol; 1997; 42(4):213-20. PubMed ID: 9586330
    [No Abstract]   [Full Text] [Related]  

  • 38. Red bayberry extract inhibits growth and virulence gene expression of the human pathogen Vibrio cholerae.
    Zhong Z; Yu X; Zhu J
    J Antimicrob Chemother; 2008 Mar; 61(3):753-4. PubMed ID: 18222950
    [No Abstract]   [Full Text] [Related]  

  • 39. [Possibility of quickly determining the sensitivity of cholera vibrio to antibiotics using erythrocytic diagnosticum].
    Roshchin VV; Suleĭmenov BM; Semiotrochev VL
    Lab Delo; 1971; 8():501-2. PubMed ID: 4114051
    [No Abstract]   [Full Text] [Related]  

  • 40. Typing and antibiotic susceptibility patterns of Vibrio cholerae during six consecutive cholera seasons in north India.
    Kaur H; Lal M
    Trop Gastroenterol; 1998; 19(2):59-61. PubMed ID: 9752752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.